Sector portfolio · Private equity · United States

RA Capital Management's Biotech portfolio

RA Capital Management has backed 197 Biotech startups in rounds we track, $38B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

197startups backed
6stages
$38Braised between them
Stage not reportedbiggest stage

RA Capital Management's whole portfolioRA Capital Management's profile

Stage not reported

65

+41 more

Series C and later

52

+28 more

Series B

46

+22 more

Series A

27

+3 more

Growth

5

Pre-seed and seed

2

Segment by segment

Stage not reported

65 startups · $12B raised

  1. Apogee TherapeuticsApogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.United States$1.3B
  2. Candid TherapeuticsCandid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.United States$875M
  3. Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.United States$600M
  4. Legend BiotechLegend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.United States$576M
  5. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  6. Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530M
  7. Avalo TherapeuticsAvalo Therapeutics is a clinical-stage biopharmaceutical company.United States$501M
  8. New Amsterdam PharmaNew Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.Netherlands$453M

Series C and later

52 startups · $11B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. Avidity BiosciencesSynapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.United States$790M
  3. ModernaLearn how we’re changing the world of medicine.United States$675M
  4. Orchard TherapeuticsOrchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.United Kingdom$377M
  5. GalectoGalecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.Denmark$365M
  6. Solid BiosciencesSolid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.United States$333M
  7. Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
  8. ZLZai LabChina$310M

Series B

46 startups · $7.0B raised

  1. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  2. Wave Life SciencesWave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States$434M
  3. Artiva BiotherapeuticsArtiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.United States$420M
  4. Global Blood TherapeuticsGBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.United States$389M
  5. Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
  6. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  7. Aeglea BioTherapeuticsAeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.United States$266M
  8. SurrozenSurrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.United States$258M

Series A

27 startups · $5.7B raised

  1. CelcuityCelcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.United States$1.0B
  2. Tango TherapeuticsTango Therapeutics is a biotechnology company that is developing next generation cancer therapies.United States$852M
  3. Dyne TherapeuticsDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.United States$828M
  4. Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
  5. 89Bio89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.United States$348M
  6. Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
  7. GentiBioGentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapiesUnited States$157M
  8. Slate MedicinesSlate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.United States$130M

Growth

5 startups · $2.0B raised

  1. Intarcia TherapeuticsIntarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.United States$1.1B
  2. CellCentricCellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.United Kingdom$525M
  3. Element BiosciencesElement Biosciences is a biotechnology company based in San Diego, founded in 2017 by former Illumina scientists.United States$190M
  4. TARIS BiomedicalTARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.United States$84M
  5. AmpliPhi BiosciencesSeasoned drug development teams from AmpliPhi Biosciences Corporation and C3J Therapeutics have joined together to form Armata PhaUnited States$44M

Pre-seed and seed

2 startups · $29M raised

  1. Avilar TherapeuticsAvilar Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2020.United States$15M
  2. Pahr TherapeuticsPahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.United States$14M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names RA Capital Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioRA Capital Management's Pharma portfolio44 startups · $8.1BSector portfolioRA Capital Management's Healthtech portfolio10 startups · $1.2BPortfolio mapRA Capital Management portfolio map264 startups · $48BCo-investorsWho invests with RA Capital Management152 co-investorsSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8B

Raising from investors like RA Capital Management?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps